Stock Details
FRE.DE is Fresenius SE & Co. KGaA's stock. Stock exchange XETRA (Currency EUR). Average price in 50 days is 33.37โ‚ฌ. Average daily volumn in 3 months 1.4M. Market cap 21.58B



Stock symbol : FRE.DE. Exchange : XETRA. Currency : EUR
Lastest price : 32.51โ‚ฌ. Total volume : 1.08M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Fresenius SE & Co. KGaA (FRE.DE)
Last Price
32.51โ‚ฌ
Change
0.33
Volume
1.08M

Previous Close31.79
Open32.01
Day Range31.80-32.48
Bid32.27 x N/A
Ask32.29 x N/A
Volume1.08M
Average Volume1.4M
Market Cap21.58B
Beta1.27
52 Week Range26.69-47.60
Trailing P/E10.52
Foward P/E9.03
Dividend (Yield %)2.76%
Ex-Dividend Date2022-05-16



Financial Details


According to Fresenius SE & Co. KGaA's financial reports the company's revenue in 2021 were 37.52B an increase( +2.78%) over the years 2020 revenue that were of 36.28B. In 2021 the company's total earnings were 1.82B while total earnings in 2020 were 1.71B(0%).


Loading ...



Organization

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi s... egment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hรถhe, Germany.

Market Cap:
21.58B
Revenue:
37.52B
Total Assets:
71.96B
Total Cash:
2.76B


News about "Fresenius SE & Co. KGaA"

fresenius-se-co-kgaa-frafre-pt-set-at-3600-by-deutsche-bank-rese-image

Fresenius SE & Co. KGaA (FRA:FRE) PT Set at โ‚ฌ36.00 by Deutsche Bank Reseโ€ฆ

Source from : Defense World - 2 days ago

Fresenius SE & Co. KGaA (FRA:FRE โ€“ Get Rating) received a โ‚ฌ36.00 ($38.30) price target from Deutsche Bank Reseโ€ฆ in a research note issued on Thursday, Borsen Zeitung reports. Deutsche Bank Reseโ€ฆโ€™s ...See details»


fresenius-se-co-kgaa-frafre-given-a-3330-price-target-by-jpmorgan-chase-co-analysts-image

Fresenius SE & Co. KGaA (FRA:FRE) Given a โ‚ฌ33.30 Price Target by JPMorgan Chase & Co. Analysts

Source from : Defense World - 2 days ago

JPMorgan Chase & Co. set a โ‚ฌ33.30 ($35.43) target price on Fresenius SE & Co. KGaA (FRA:FRE โ€“ Get Rating) in a research report released on Wednesday morning, Borsen Zeitung reports. Other equities ...See details»


Fresenius SE & Co. KGaA (FRE) โ€“ Analystsโ€™ Weekly Ratings Updates

Source from : ETF Daily News - 3 days ago

Fresenius SE & Co. KGaA has a fifty-two week low of โ‚ฌ60.16 ($64.00) and a fifty-two week high of โ‚ฌ80.00 ($85.11). Fresenius SE & Co KGaA, a health care company, provides products and services ...See details»


Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Downgraded by Zacks Investment Research to Sell

Source from : ETF Daily News - 9 days ago

Zacks Investment Research lowered shares of Fresenius SE & Co. KGaA (OTCMKTS:FSNUY โ€“ Get Rating) from a hold rating to a sell rating in a research report report published on Wednesday ...See details»


Fresenius SE & Co KGaA - Stock Quote FSNUF

Source from : Morningstar%2c Inc. - 4 days ago

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...See details»


Fresenius SE & Co. KGaA ADR

Source from : Wall Street Journal - 3 days ago

1 Day FSNUY 0.61% DJIA 0.60% S&P 500 0.95% Health Care/Life Sciences -0.37% ...See details»


Fresenius SE & Co KGaA - Stock Dividends FRE

Source from : Morningstar%2c Inc. - 5 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»


DGAP-DD: Fresenius SE & Co. KGaA english

Source from : Business Insider - 8 days ago

Archive at www.dgap.de 75275 20.05.2022 SHARE THIS POST Fresenius NewsMORE Related Stocks Find News News ...See details»


Fresenius Medical Care AG & Co. KGaA

Source from : Wall Street Journal - 12 days ago

Fresenius Medical Care AG & Co. KGaA, Fresenius Management SE, Else Krรถner-Fresenius-Stiftung Dorothea Wenzel Member-Supervisory Board Fresenius Medical Care AG & Co. KGaA, H. Lundbeck A/S ...See details»


Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet succeeds Rice Powell as CEO of the Management Board of Fresenius Medical Care

Source from : dgap - 24 days ago

Fresenius Medical Care AG & Co. KGaA / Key word(s): Personnel Fresenius Medical Care ... Dr. Carla Kriwet will also be a member of the Management Board of Fresenius Management SE. Fresenius Medical ...See details»


Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care

Source from : dgap - 24 days ago

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Personnel Fresenius Medical Care ... Dr. Carla Kriwet will also be a member of the Management Board of Fresenius Management SE. Helen ...See details»


Local Anesthesia Drugs Market Size, Trends, Growth Analysis and Forecast from 2022-2028 | Pfizer Inc, Fresenius Se & Co. Kgaa, Aspen Pharmacare

Source from : Digital Journal - 12 days ago

Gravitas Market Insights provides in-depth research of the Local Anesthesia Drugs Market with complete insights into significant factors and characteristics impacting the potential growth of the ...See details»


Fresenius SE & Co KGaA

Source from : Newsweek - 1 month ago

Fresenius SE & Co. KGaA is a European health care company based in Bad Homburg, Germany. The Fresenius Group provides products and services for dialysis, hospitals as well as inpatient and ...See details»


DGAP-DD: Fresenius SE & Co. KGaA english

Source from : Business Insider - 9 days ago

Archive at www.dgap.de 75201 19.05.2022 SHARE THIS POST Fresenius NewsMORE Related Stocks Find News News ...See details»